Medicare billing address
CMS Medicare provider billing file
3922 Woodley RdSuite 200
Toledo, OH 43606
CMS public data · NPI 1174506109
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Mohammed A Abusamieh, M.D
Specialty
Credential
M.D
NPI
1174506109
Primary source state
OH
Data retrieval date
July 27, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Mohammed A Abusamieh, M.D from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
3922 Woodley RdCMS Doctors & Clinicians file
3830 Woodley RdCMS Doctors & Clinicians file
4235 Secor RdIn the 2024 CMS provider billing file, this NPI had 543 Medicare beneficiaries and 94,479 total services. The average beneficiary age was 74, and the average HCC risk score was 1.4.
Total Medicare allowed amount
$1,770,138.31
Total Medicare payment amount
$1,390,893.86
Medicare beneficiaries
543
Total services
94,479
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Osteoporosis
31%
CMS beneficiary-panel share
Diabetes
30%
CMS beneficiary-panel share
Chronic kidney disease
29%
CMS beneficiary-panel share
Mood disorders
28%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, golimumab, 1 mg, for intravenous use | 25,400 | $11.46 |
| Injection, denosumab, 1 mg | 8,340 | $25.57 |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 8,300 | $42.63 |
| Injection, infliximab, excludes biosimilar, 10 mg | 7,720 | $31.41 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 1,190 | $120.35 |
| Injection, methylprednisolone sodium succinate, 5 mg | 975 | $0.29 |
| Injection, methylprednisolone acetate, 1 mg | 570 | $0.13 |
| Administration of chemotherapy into vein, 1 hour or less | 494 | $116.45 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 485 | $6.96 |
| Insertion of needle into vein for collection of blood sample | 406 | $8.63 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1174506109. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Prednisone | Prednisone | 1,530 | 2,366.3 | $8,685.31 |
| 2 | Methotrexate | Methotrexate Sodium | 847 | 1,664.7 | $23,712.15 |
| 3 | Tizanidine Hcl | Tizanidine Hcl | 847 | 1,400.7 | $5,882.69 |
| 4 | Alendronate Sodium | Alendronate Sodium | 664 | 1,174.2 | $3,854.45 |
| 5 | Gabapentin | Gabapentin | 504 | 776 | $8,261.68 |
| 6 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 493 | 914 | $23,864.33 |
| 7 | Meloxicam | Meloxicam | 463 | 903.7 | $2,482.50 |
| 8 | Tramadol Hcl | Tramadol Hcl | 310 | 312 | $2,312.21 |
| 9 | Diclofenac Sodium | Diclofenac Sodium | 297 | 563.1 | $5,071.01 |
| 10 | Duloxetine Hcl | Duloxetine Hcl | 249 | 474 | $3,926.22 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
1993
Group/practice field
Toledo Clinic Incorporated
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.